Skip to main content
. 2020 May 25;29(6):565–571. doi: 10.1159/000508876

Table 2.

Comparison of risk factors between subjects without and with erectile dysfunction (ED)

Parameters Subjects without ED Subjects with ED p value*
Subjects 46 (42.6) 62 (57.4)
Age 0.001
 Q1 ≤ 47 years 15 (65.2) 8 (34.8)
 48 ≤ Q2 ≤ 53 years 17 (50.0) 17 (50.0)
 54 ≤ Q3 ≤ 57 years 8 (38.1) 13 (61.9)
 58 ≤ Q4 years 6 (20.0) 24 (80.0)
Smoking 0.130
 Never 4 (8.7) 12 (19.4)
 Smoker 25 (54.3) 23 (37.1)
 Ex-smoker 17 (37.0) 27 (43.5)
Metabolic factors
 BP ≥130/85 mm Hg or drugs 28 (60.9) 39 (62.9) 0.829
 WC ≥90 cm 27 (58.7) 30 (48.4) 0.289
 FBG ≥100 mg/dL or drugs 13 (28.3) 30 (48.4) 0.035
 TG ≥150 mg/dL or drugs 22 (47.8) 23 (37.1) 0.263
 HDL-C <40 mg/dL or drugs 13 (28.3) 18 (29.0) 0.930
Metabolic syndrome 21 (45.7) 28 (45.2) 0.960
TC/HDL-C >3.5 41 (89.1) 48 (77.4) 0.114
HOMA-IR ≥2.34 5 (10.9) 10 (16.1) 0.434

Data are presented as n (%). BP, blood pressure; WC, waist circumference; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment index-insulin resistance.

*

By χ2 test or linear by linear association.